NEWS & MEDIA

#notjustvapor

Published on December 28, 2020 By Gretchen Gailey

Don’t Forget About the Black Sheep, HEMP!

Advocates are all positioning themselves for the new year, trying to figure out how they are going to finally get cannabis legalized federally, plotting on how to slide that MORE Act through one more time…. While all this scheming is abounding in Washington, lobbyists and industry analysts should not forget about the black sheep of the family that led the way – hemp.

A new report out by Whitney Economics, “Déjà vu: An Economics Analysis of the U.S. Hemp Cultivation Industry,” looks back on the development of the U.S. Hemp Industry over the past two years and has not surprisingly found that there continues to be an enormous oversupply of hemp biomass. The average left-over biomass was 24,795 pounds per farm, resulting in over 135 million pounds across the U.S. This surplus is largely due to confusion in the regulatory process, no capacity to process the plants and farmers inability to find buyers.

One of the biggest hurdles starts with the regulators. When the 2018 Farm Bill passed legalizing hemp derived cannabis, entrepreneurial farmers jumped on the opportunity, however no regulatory framework had truly been set up by the federal government. The FDA and the USDA butted heads on who had oversight of whether or not a product was in the food supply, a nutritional supplement, or an agricultural product. Then you layer on top of that confusion from the states that are trying to run their own programs.

Producers of products were then confused by interstate commerce laws and so was the law enforcement. Many chose to keep their crops and products in the states where they grew them to try and stave off any legal issues, but all that did was limit their market and their options to process and sell. The speed of the market getting up and running was far outpacing the regulatory infrastructure that needed to be created to help the industry flourish. Meanwhile, the DEA is trying to play catch up and figure out who has jurisdiction over this new crop.

Testing regulations from the DEA’s recent Interim rules sent the industry into a tizzy, particularly in the processing sector. They stated that no hemp product or sample can be above 0.3% THC at any point in the process. This new guidance confused many because it is not uncommon for oils and extracts to test above 0.3% at some point in the process before the THC can be removed from the crude or distillate. This rule cannot stand if they want legitimate businesses to develop innovative, quality products for consumers.

The FDA doesn’t even know where to begin with hemp. Generally, FDA policy dictates that if a substance has been defined as a drug, then all future derived products are also considered drugs. However, the number of products that can be made from hemp (more than 25,000) make classifying it a farce. To help support the industry, the FDA must clarify its position on CBD. Until that happens and they allow CBD to be added to food and beverages, a major source for hemp demand will remain on the sidelines.

Hemp could become a crop that transforms our way of life and the products that we consume, but that only happens if regulators and the industry take the time to get it right. If we don’t start to work out the regulatory problems that we are seeing within the hemp space, we will be doomed to repeat them when cannabis is legalized. So, a little public service announcement to our advocates and industry lobbyists: don’t forget about hemp - the black sheep, they are part of the family too.

 

#notjustvapor

 

 

Subscribe to our Blog

Let’s Talk REQUEST A CONSULTATION

Join The Conversation

@theblincgroup

OUR CLIENTS

A few words from industry leaders

Quality control and compliance were our most important factors for choosing a hardware designer, producer and supplier. Blinc was chosen over others considered based on their reputation and experience for these key factors.
A team of rockstars across the board, from brand realignment to product development to training and support - big thank you!!!
The integrity of that medicine starts with the hardware that is used to deliver it and we knew that partnering with the Blinc Group was the best way to provide that kind of quality and reliability to our patients.
Working with Blinc Group was a completely seamless experience. Our team is very particular and detail-oriented, but Blinc was able to walk us through all our questions and queries to create a product we are stoked about.
The Blinc Group's unmatched customer service and supply chain diligence give us the peace of mind needed to provide our patients and customers with a quality product.
You guys are the best! Keep up the great work! We look forward to working more with Blinc as our hardware partner!
We could not be happier with our choice to work with The Blinc Group, and look forward to continue innovating with them in the future.
The alignment between our two companies is fantastic. Blinc takes safety and quality as seriously as we do, and the outcome of the working relationship has both teams excited...
The Blinc Group produces high quality products and provides great, attentive, and friendly customer service. We especially appreciate their documented attention to testing and compliance.
Fume Labs and the Blinc Group are incredible partners and we’re very fortunate to be working with them on our first product.